Workpackage

Publications



  1. Breems DA, Boogaerts MA, Dekker AW, Van Putten WL, Sonneveld P, Huijgens PC, Van der Lelie J, Vellenga E, Gratwohl A, Verhoef GE, Verdonck LF, Lowenberg B: Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial
    Br J Haematol 2005 Jan;128(1):59-65
    Subjects: AML · SCT
  2. Crawley C, Szydlo R, Lalancette M, Bacigalupo A, Lange A, Brune M, Juliusson G, Shimoni A, Gratwohl A, Komarnicki M, Vitek A, Mayer J, Zander A, Sierra J, Rambaldi A, Ringden O, Niederwieser D, Apperley JF: Outcomes of reduced intensity transplantation for chronic myeloid leukaemia: An analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
    Blood 106/9:2969-2976 (2005)
    Subjects: SCT
  3. De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simoes BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R: Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome
    Haematologica 2005 Feb;90(2):232-7
    Subjects: SCT
  4. Dreger P, Brand R, Milligan D, Corradini P, Finke J, Deliliers GL, Martino R, Russell N, van Biezen A, Michallet M, Niederwieser D: Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: A population-matched analysis
    Leukemia 19:1029-1033 (2005)
    Subjects: CLL · SCT
  5. Gahrton G, Iacobelli S, Apperley J, Bandini G, Björkstrand B, Bladé J, Boiron JM, Cavo M, Cornelissen J, Corradini P, Kröger N, Ljungman P, Michallet M, Russell NH, Samson D, Schattenberg A, Sirohi B, Verdonck LF, Volin L, Zander A, Niederwieser D: The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants
    Bone Marrow Transpl 35:609-617 (2005)
    Subjects: SCT
  6. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kotter I, Kozak T, Lisukov I, Lowenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A;: Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Autologous hematopoietic stem cell transplantation for autoimmune diseases.
    Bone Marrow Transplant 2005 May;35(9):869-79
    Subjects: SCT
  7. Gratwohl A: Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation
    Haematologica 2005 Feb;90(2):151
    Subjects: SCT
  8. Gratwohl A: Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation
    Haematologica 2005 Feb;90(2):151
    Subjects: SCT
  9. Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A: Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Bone Marrow Transplant 2005 Oct;36(7):575-90
    Subjects: SCT
  10. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kotter I, Kozak T, Lisukov I, Lowenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A: Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Autologous hematopoietic stem cell transplantation for autoimmune diseases
    Bone Marrow Transplant 2005 May;35(9):869-79
    Subjects: SCT
  11. Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P, Einsele H, Cordonnier C: Acute and Chronic Leukemia Working Parties; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time
    Bone Marrow Transplant 2005 Nov;36(9):757-69
    Subjects: SCT
  12. Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW, Gratwohl A, van Laar JM, Mayes MD, Martin R, McSweeney PA, Muraro PA, Openshaw H, Saccardi R, Sandmaier BM, Forman SJ, Nash RA: Workshop participants. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
    Biol Blood Marrow Transplant 2005 Nov;11(11):862-70
    Subjects: SCT
  13. Hegenbart U, Niederwieser D, Sandmaier BM, Maris MB, Shizuru JA, Greinix H, Cordonnier C, Rio B, Gratwohl A, Lange T, Al-Ali H, Storer B, Maloney D, McSweeney P, Chauncey T, Agura E, Bruno B, Maziarz RT, Petersen F, Storb R.: Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors
    J Clin Oncol 2006 Jan 20;24(3):444-53
    Subjects: SCT
  14. Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S, Gratwohl A, Ferrant A, Elmaagacli A, Schwertfeger R, Locasciulli A, Zander A, Maniatis A, Niederwieser D, Ruutu: Development of leukemia in donor cells after allogeneic stem cell transplantation – a survey of the European Group for Blood and Marrow Transplantation (EBMT)
    Haematologica 2005, 90/7:969-975
    Subjects: SCT
  15. Kerbauy FR, Storb R, Hegenbart U, Gooley T, Shizuru J, Al-Ali HK, Radich JP, Maloney DG, Agura E, Bruno B, Epner EM, Chauncey TR, Blume KG, Niederwieser D, Sandmaier BM: Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
    Leukemia 2005, 19:990-997
    Subjects: SCT
  16. Lange T, Bumm T, Mueller M, Otto S, Al-Ali HK, Grommisch L, Musiol S, Franke C, Krahl R, Niederwieser D, Deininger: Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation
    Leukemia 19/7:1262-1265
    Subjects: SCT
  17. Martinez MT, Bucher Ch, Stussi G, Heim D, Buser A, Tsakiris DA, Tichelli A, Gratwohl A, Passweg JR: Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants
    Bone Marrow Transplant 2005 Dec;36(11):993-1000
    Subjects: SCT
  18. Niederwieser D: Haematopoietic cell transplantation after reduced intencity contitioning. European Journal of Hospital Pharmacy
    European Journal of Hospital Pharmacy 11/5:16-18
    Subjects: SCT
  19. Niederwieser D, Cross M, Lange T, Gentilini C, Haffner C, Pönisch W, Raida M, Al-Ali H: Hematopoietic cell transplantation in acute myeloid leukemia
    Hematology 1:118-122
    Subjects: SCT
  20. Niederwieser D, Gentilini C, Hegenbart U, Lange T, Becker C, Wang SY, Bartsch K, Pönisch W, Raida M, Al-Ali H: Allogeneic stem cell transplantation (HCT) following reduced-intensity conditioning in patients with acute
    Crit Rev Oncol Hematol 2005 Nov;56(2):275-81
    Subjects: SCT
  21. Ruutu T, Corradini P, Gratwohl A, Holler E, Apperley J, Dini G, Schmitz N, Socié G, Niederwieser D: Use of intrathecal phrophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the european group for blood and marrow transplantation (EBMT)
    Bone Marrow Transpl 35/2:221-224
    Subjects: SCT
  22. Schmitz N, Beksac M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, Russell N, Apperley J, Szerm J, Bradstock K, Buzyn A, Schlegelberger B, Matcham J, Gratwohl A: Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial
    Haematologica 2005 May;90(5):643-8
    Subjects: SCT
  23. Wills S, Lange T, Demehri S, Otto S, Crossmann L, Niederwieser D, Stoffregen E, McWeeney S, Kovacs I, Park B, Druker BJ, Deininger MW: High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy
    Blood 106/6:2128-2137
    Subjects: SCT
  24. Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T: Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres
    Bone Marrow Transplant 36/7:601-603
    Subjects: SCT

 

Print this Document   Sitemap   Contact  
EUTOS
EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe More ...


 
top